On August 28, 2019 LIDDS AB reported that Professor Laurence Klotz, a world leading expert in Active Surveillance of prostate cancer patients, reported that it will present the results of the LPC-004 prostate cancer study at the 11th European Multidisciplinary Congress on Urological Cancers, EMUC19 (Press release, Lidds, AUG 28, 2019, View Source [SID1234555905]). The oral presentation is scheduled for November 16, 2019.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Professor Klotz is one of the LPC-004 study investigators and is Professor at the University of Toronto Division of Urology at the Sunnybrook Health Sciences Centre in Canada.

-I am very pleased that the Phase IIb study results will be presented at EMUC by the expert and key opinion leader Professor Klotz, says Monica Wallter, CEO, LIDDS.

LIDDS will announce the preliminary results of the LPC-004 study in September. The final study report is scheduled for the last quarter of 2019.